Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
作者： Huayun Deng , Haibei Hu , Ye Fang , Haiyan Sun , Mingqian He
DOI:
关键词:
摘要: Disclosed are compositions and methods for the prevention and/or treatment of diseases which pathophysiologically related to GPR35, GPR35-hERG signaling complex. For example, disclosed compounds preventing treating GPR35 in a subject.
google.it 参考文章(47)
Ibragim Gaidarov, Jun Qiu, Zhi Liang Chu, James N Leonard, Philip J Skinner, Joel E Gatlin, P Douglas Boatman, David J Unett, Modulators of gpr35 for the treatment of metabolic-related disorders ,(2005)
Hans Bundgaard, Design of prodrugs Elsevier , Sole distributors for the USA and Canada, Elsevier Science Pub. Co.. ,(1985)
J. F. W. McOmie, Protective Groups in Organic Chemistry ,(2012)
Chongxi Yu, Lina Xu, Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate ,(2006)
Bruce R. Conklin, Zvi Farfel, Kevin D. Lustig, David Julius, Henry R. Bourne, Substitution of three amino acids switches receptor specificity of Gqα to that of Giα Nature. ,vol. 363, pp. 274- 276 ,(1993) , 10.1038/363274A0
AE Shrimpton, BR Braddock, LL Thomson, CK Stein, JJ Hoo, Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clinical Genetics. ,vol. 66, pp. 537- 544 ,(2004) , 10.1111/J.1399-0004.2004.00363.X
Kimihiko Tomotoshi, Hiroko Kachi, Yasuhito Taniguchi, Tohru Komada, Katsuhiro Shinjo, Screening method for emulators of neural activity and digestive system using gpr35 ,(2005)
Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman, Mary E. Abood, Treatment of disorders associated with G protein-coupled receptor 35 (GPR35) RTI International. P.O. Box 12194, Research Triangle Park, NC 27709-2194. Tel: 919-541-6000; e-mail: publications@rit.org; Web site: http://www.rti.org. ,(2010)
Harry G Brittain, None, Polymorphism in Pharmaceutical Solids ,(1999)
Charles Y. F. Young, Nianzeng Xing, Methods and compositions for inhibiting the proliferation of prostate cancer cells ,(2001)